Phibro Animal Health (PAHC)
(Delayed Data from NSDQ)
$18.55 USD
+0.09 (0.49%)
Updated May 24, 2024 03:59 PM ET
After-Market: $18.55 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
A Value B Growth F Momentum B VGM
Brokerage Reports
0 items in cart
Phibro Animal Health Corporation [PAHC]
Reports for Purchase
Showing records 21 - 40 ( 250 total )
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Company: Phibro Animal Health Corporation
Industry: Medical - Products
SGA Expense Management Drives In- Line EPS Quarter
Provider: Roth Capital Partners, Inc.
Analyst: WRIGHT B